Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/4/16 → 11/14/19 |
Funding
- NewLink Genetics: $120,459.00
15-NEURO-06-NLG (NLG-2102) A Phase 1/2 Study of the Combination of Indoximod + Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors
- Villano, PhD, John (PI)
- St Clair, William (CoI)
- Thind, Ravneet (CoI)